Grant: Engage Grants Program
University of British Columbia
$25,000.00
Molecular imprint polymer for urine biomarker isolation
EF 2015-16
Résumé
Early detection of cancer saves lives. This project is related to a patients screening technology for cancers at
very early stages using the quantification of an exogenous metabolite in urine. BioMark Technologies Inc.
developed this technology based on the fact that increased the increased acetylation of an exogenous
compound amantadine to acetylamantadine (AcAm) is strongly correlated to the up-regulation of the enzyme
spermine/spermidine N-acetyltransferase (SSAT1), which is correlated to several types of cancers. The
currently available analytical methods for the quantification of AcAm are laborious and costly, and efforts to
reduce the cost with the direct use of Raman spectrometry have proven difficult because of the contamination
of matrix material on the probes. In this project we propose to use molecular imprint polymer (MIP) to clean
up the sample and enrich the target analyte AcAm, so that both the time and the cost required for the
quantitative analysis can be significantly reduced to make this technology readily available in all clinical labs.
The developed technology can be readily transferred to BioMark Technologies Inc., and will be of direct
benefit to the Canadian economy and the health and well-being of Canadians.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
484791-2015
Name nom
Chen, David
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
515
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Instrumentation technology
Area of application fr
Technologie de l'instrumentation
Research subject code
3503
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Separation methods
Research subject fr
Méthodes de séparation
Partie
1
Nb partie
1
Application title
Molecular imprint polymer for urine biomarker isolation
Keyword
NSERC
Application summary
Early detection of cancer saves lives. This project is related to a patients screening technology for cancers at
very early stages using the quantification of an exogenous metabolite in urine. BioMark Technologies Inc.
developed this technology based on the fact that increased the increased acetylation of an exogenous
compound amantadine to acetylamantadine (AcAm) is strongly correlated to the up-regulation of the enzyme
spermine/spermidine N-acetyltransferase (SSAT1), which is correlated to several types of cancers. The
currently available analytical methods for the quantification of AcAm are laborious and costly, and efforts to
reduce the cost with the direct use of Raman spectrometry have proven difficult because of the contamination
of matrix material on the probes. In this project we propose to use molecular imprint polymer (MIP) to clean
up the sample and enrich the target analyte AcAm, so that both the time and the cost required for the
quantitative analysis can be significantly reduced to make this technology readily available in all clinical labs.
The developed technology can be readily transferred to BioMark Technologies Inc., and will be of direct
benefit to the Canadian economy and the health and well-being of Canadians.